Showing results (181-190 of 330) with videos related to

Sort By:
Pageof 33
Psychiatry and Clinical Neurosciences|April 23, 2021
Efficacy and safety of lurasidone in acutely psychotic patients with schizophrenia: A 6-week, randomized, double-blind, placebo-controlled studyMasaomi Iyo, Jun Ishigooka, Masatoshi Nakamura, et al.
BMC Research Notes|April 17, 2021
Establishment of a Japanese version of the Sick, Control, One Stone, Fat, and Food (SCOFF) questionnaire for screening eating disorders in university studentsYutaka Hosoda, Toshiyuki Ohtani, Hisashi Hanazawa, et al.
European Eating Disorders Review : the Journal of the Eating Disorders Association|October 21, 2015
Repetitive Transcranial Magnetic Stimulation Changes Cerebral Oxygenation on the Left Dorsolateral Prefrontal Cortex in Bulimia Nervosa: A Near-Infrared Spectroscopy Pilot StudyChihiro Sutoh, Yasuko Koga, Hiroshi Kimura, et al.
Frontiers in Psychiatry|June 14, 2018
White Matter Features Associated With Autistic Traits in Obsessive-Compulsive DisorderMasaru Kuno, Yoshiyuki Hirano, Akiko Nakagawa, et al.
Psychiatry Research|January 1, 2014
A positive correlation between serum levels of mature brain-derived neurotrophic factor and negative symptoms in schizophreniaTomihisa Niitsu, Tamaki Ishima, Taisuke Yoshida, et al.
Psychopharmacology|July 27, 2017
Alterations in glutamatergic signaling in the brain of dopamine supersensitivity psychosis and non-supersensitivity psychosis model ratsYasunori Oda, Yuko Fujita, Kengo Oishi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 20, 2009
Enhancement of acoustic prepulse inhibition by contextual fear conditioning in mice is maintained even after contextual fear extinctionDaisuke Ishii, Daisuke Matsuzawa, Yuko Fujita, et al.
SAGE Open Medical Case Reports|June 20, 2020
Successful rechallenge with paliperidone after clozapine treatment for a patient with dopamine supersensitivity psychosisRemiko Kobayashi, Yasunori Oda, Ryunosuke Hayatsu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 13, 2002
Metabolite alterations in basal ganglia associated with methamphetamine-related psychiatric symptoms. A proton MRS studyYoshimoto Sekine, Yoshio Minabe, Masayoshi Kawai, et al.
Psychiatry Research|July 5, 2005
No changes in serum epidermal growth factor levels in patients with schizophreniaKenji Hashimoto, Eiji Shimizu, Naoya Komatsu, et al.
Pageof 33